Teligent, Inc. To Present At 29th Annual ROTH Conference On March 13, 2017

BUENA, N.J., March 13, 2017 /PRNewswire/ -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey based specialty generic pharmaceutical company, will be presenting at the 29^th Annual ROTH Conference. The Conference is taking place on March 12-15, 2017 at The Ritz Carlton, Dana Point, CA.

Jason Grenfell-Gardner, President and CEO and Jenniffer Collins, Chief Financial Officer of Teligent, Inc. will present on Monday, March 13, 2017 at 11:30 a.m. PDT. 

The presentation will be webcast and will be accessible online on the investors section of the Company's website at http://www.teligent.com.  A replay will be available for 30 days.  

About Teligent, Inc.
Teligent is a specialty generic pharmaceutical company.  Our mission is to be a leading player in the specialty generic prescription drug market.  Learn more on our website www.teligent.com.

SOURCE Teligent, Inc.

Related Links

http://www.teligent.com